✦ LIBER ✦

Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note

✍ Scribed by K. P. R. Chowdary; Y. Srinivasa Rao

Book ID: 111767091
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 349 KB
Volume: 4
Category: Article
ISSN: 1530-9932
DOI: 10.1208/pt040339

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and Evaluation In Vitro of Contro

Design and Evaluation In Vitro of Controlled Release Mucoadhesive Tablets Containing Chlorhexidine

✍ Carlo Ceschel, Gian; Bergamante, Valentina; Calabrese, Valeria; Biserni, Stefano 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 206 KB

Galactomannan gum coated mucoadhesive mi

Galactomannan gum coated mucoadhesive microspheres of glipizide for treatment of type 2 diabetes mellitus: In vitro and in vivo evaluation

✍ Punam Gaba; Sarbjot Singh; Monika Gaba; G.D. Gupta 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 940 KB

Development of oral controlled release p

Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). II. In vitro and in vivo evaluation

✍ Ryoichi Morita; Ritsuko Honda; Yoshiteru Takahashi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 132 KB

In Vitro-In Vivo Evaluation of a Control

In Vitro-In Vivo Evaluation of a Controlled Release Buccal Bioadhesive Device for Oral Drug Delivery

✍ Deepak Tiwari; David Goldman; Chris Town; Robert Sause; Parshotam L. Madan 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 1004 KB

Oral heparin delivery: Design and in viv

Oral heparin delivery: Design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system

✍ Thierry Schmitz; Verena M. Leitner; Andreas Bernkop-Schnürch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Low molecular weight heparin (LMWH) is an agent of choice in the anticoagulant therapy and prophylaxis of thrombosis and coronary syndromes. However, the therapeutic use is partially limited due to a poor oral bioavailability. It was therefore the aim of this study to design and evaluate a highly ef

Novel mucoadhesive extended release tabl

Novel mucoadhesive extended release tablets for treatment of oral candidosis: “In vivo” evaluation of the biopharmaceutical performance

✍ J.M. Llabot; R.H. Manzo; D.A. Allemandi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Mucoadhesive tablets containing nystatin (10 mg) were evaluated in vivo. The assays were carried out with 12 healthy volunteers and the concentration of nystatin in saliva was determined at different times. Tablets remained attached to the buccal mucosa during 270 min +/- 30 min. No evidence of ulce